Updated: 12:35 PM EDT Apr 5, 2021
Hide Transcript
Show Transcript IT HAS JUST BEEN ONE DAY SINCE OFFICIALS AT THIS COMPANY CONFIRMED ON THE RECORD FOR THE FIRST TIME THAT THEY HAVE YET TO GET FDA APPROVAL TO MAKE THE VACCINE. THEY CHALKED IT UP TO PROCESS YESTERDAY, BUT TODAY THERE IS A PAIR OF REPORTS THAT POINT TO SOME OTHER REASONS WHY. ACCORDING TO THE AP EMERGENT HAS , BEEN REPEATEDLY CITED FOR QUALITY CONTROL ISSUES. THE NEW YORK TIMES REPORTING, A A MIXUP HERE LED TO 15 MILLION DOSES GOING IN THE TRASH. I JUST BECAME AWARE OF IT YESTERDAY AS IT BECAME PUBLI AND MOST OF THE WORLD BECAME AWARE. IT WAS NOT MENTIONED BY THE WHITE HOUSE DURING OUR TUESDAY CALL. MARYLAND GOVERNOR LARRY HOGAN DIDN’T HEAR ABOUT THE PROBLEM WITH EMERGENT BIOSOLUTIONS’ JOHNSON AND JOHNSON VACCINE PRODUCTION FROM THE FEDS. HE TOLD REPORTERS TODAY HE FOUND OUT LIKE NEARLY EVERYONE ELSE, THE NEW YORK TIMES REPORTING THAT A MASSIVE MISTAKE AT EMERGENT’S BAYVIEW MANUFACTURING P
Updated: 5:27 PM EST Jan 28, 2021 By Phil Yacuboski The Johnson & Johnson one-shot coronavirus vaccine is expected to be a game-changer in fighting COVID-19 and it will be made in Baltimore.|| Coronavirus updates | Maryland s latest numbers | Get tested | Vaccine Info ||Workers at Emergent BioSolutions near Johns Hopkins Bayview Medical Center said they are ready to go as soon as the U.S. Food and Drug Administration gives approval.Gaithersburg-based Emergent BioSolutions has about 1,000 employees at two Baltimore locations that will make the Johnson & Johnson coronavirus vaccine. Over the coming months, we expect to manufacture hundreds of millions of doses to keep doses flowing to the American population, said Sean Kirk, executive vice president of manufacturing and technical operations for Emergent BioSolutions.Maryland online vaccination site locatorVaccine Data DashboardMaryland vaccination plan FAQsAs part of the clinical trials, the company is already maki